Physician profile
Benjamin W Mcclellan
NPI 1629584461
$5,272.59
in general payments reported to CMS, 2019-2025
37 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.51 · 2022: $999 · 2023: $1,406 · 2024: $1,507 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,242.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,153.04 | 2022-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Abbvie INC. | $1,059.50 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $375.52 | 2022-2025 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $361.77 | 2022-2025 | Nuplazid |
| Pfizer INC. | $280.11 | 2022-2025 | |
| Lundbeck LLC | $265.04 | 2023-2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company Ltd. | $232.08 | 2022 | |
| Lilly USA, LLC | $202.87 | 2022-2023 | Emgality, Reyvow |
| Inspire Medical Systems, INC. | $200.14 | 2023-2025 | Inspire |
| Axsome Therapeutics, INC. | $142.62 | 2024-2025 | Sunosi |
| Harmony Biosciences LLC | $136.40 | 2023-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $95.32 | 2024-2025 | Lumryz |
| Genzyme Corporation | $90.86 | 2022 | |
| Impel Pharmaceuticals INC. | $84.88 | 2023 | Trudhesa |
| Neurelis, INC. | $64.59 | 2022-2023 | Valtoco |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $48.36 | 2024 | Nourianz |
| Scilex Pharmaceuticals INC. | $36.90 | 2023-2024 | Ztlido |
| Jazz Pharmaceuticals INC. | $36.45 | 2025 | |
| Boston Scientific Corporation | $33.71 | 2024 | Watchman Access System |
| Sk Life Science, INC. | $32.64 | 2023 | |
| Sumitomo Pharma America, INC. | $30.44 | 2023-2024 | Aptiom |
| Takeda Pharmaceuticals U.S.A., INC. | $30.43 | 2024 | Hyqvia |
| Supernus Pharmaceuticals, INC. | $26.22 | 2022 | |
| Mdd US Operations, LLC | $25.79 | 2022-2025 | |
| Emd Serono, INC. | $21.43 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.12 | 2022 | |
| Acorda Therapeutics, INC | $19.25 | 2024 | Inbrija |
| Novo Nordisk INC | $18.97 | 2023 | Wegovy |
| Vanda Pharmaceuticals INC. | $17.99 | 2025 | Ponvory |
| Amneal Pharmaceuticals LLC | $17.46 | 2022 | |
| Ucb, INC. | $17.27 | 2025 | Fintepla |
| Astrazeneca Pharmaceuticals Lp | $17.18 | 2022 | |
| Almatica Pharma LLC | $17.05 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.62 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.31 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.20 | 2021 | |
| 3b Medical, INC. | $11.06 | 2023 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Mcclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.